Sosa-Caballero A

Language: Spanish
References: 8
Page: 87-89
PDF size: 76.39 Kb.

Text Extraction

No abstract

REFERENCES

1. Schlumberger M, Hitzel A, Toubert ME, Corone C, Troalen F, Schlageter MH, Claustrat S, Koscienly S, Taieb D, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Torlontano M, Tenebaum F, Bardet S, Bussiere F, Girad JJ, Morel O, Schnnegans O, Schlienger JL, Prost A, So D, Archmbeaud F, Ricard M, Benhamou E. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 2007; 92: 2487-2495.

2. Lervasi A, Lervasi G, Bottoni A, Annicchiarico C, Cecco P Di, Zucchelli GC. Diagnostic performance of a new highly sensitive thyroglobulin immunoassay. J Endocrinol 2004; 182: 287-294.

3. www.beckmancoulter.com/bulletin9073g

4. Castagna MG, Tala HP, Cipri C, Belardini V, Fioravanti C, Pasqui L, Sestini F, Theodoropoulou A, Pacini F. The use of ultrasensitive thyroglobulin assays reduces but not abolishes the need for TSH stimulation in patients with differentiated thyroid carcinoma. J Endocrinol Invest 2011 as DOI: 10.3275/7571.

5. Mazzaferri EL. Will highly sensitive thyroglobulin assays change the management of thyroid cancer? Clin Endocrinol (Oxf) 2007; 67: 321-323.

6. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 3668-3673.

7. Giovanella L. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management. Clin Chem Lab Med 2008; 46: 1067-1073.

8. Rosario PW, Purisch S. Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/mL determined by traditional assays? Clin Endocrinol (Oxf) 2008; 68: 338-342.